Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection

Published:2016-08 Issue:8 Volume:2 Page:e91
ISSN:2373-8731
Container-title:Transplantation Direct
language:en
Short-container-title:Transplantation Direct

Author:

Waiser Johannes,Duerr Michael,Schönemann Constanze,Rudolph Birgit,Wu Kaiyin,Halleck Fabian,Budde Klemens,Lachmann Nils

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference24 articles.

1. Antibody-mediated rejection criteria—an addition to the Banff 97 classification of renal allograft rejection;Am J Transplant,2003

2. Anti-human leukocyte antigen and donor-specific antibodies detected by Luminex posttransplant serve as biomarkers for chronic rejection of renal allografts;Transplantation,2009

3. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence;Am J Transplant,2012

4. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation;Am J Transplant,2008

5. The treatment of acute antibody-mediated rejection in kidney transplant recipients—a systematic review;Transplantation,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of determinants and outcome of early and late acute antibody mediated rejection (ABMR);Indian Journal of Nephrology;2023

2. Therapeutic Opportunities for Immunoreceptor-Engineered T Cell Therapy for Modulation of Alloimmunity;The Journal of Immunology;2022-11-15

3. Poor Outcomes in Patients With Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions;Frontiers in Medicine;2022-05-12

4. Evaluation of severity of delayed graft function in kidney transplant recipients;Nephrology Dialysis Transplantation;2021-10-19

5. Rejection Challenges: Diagnosis and Management;Challenges in Pediatric Kidney Transplantation;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3